DailyIQ
|
Sector:Consumer DefensiveAll sectors
Last updated 5 minutes ago

CLX·The Clorox Company

$.
+. (+.%)
Pre-Market
High
$99.50
Open
$99.50
Market Cap
11.82B
52W High
$132.03
Low
$98.21
P. Close
$98.88
P/E
15.63
52W Low
$84.70
Fwd P/E
58.27
DailyIQ Est.
$95.89
Technical Score (1D)
64
BUY
News Sentiment
46
MIXED
Clorox will publish its fourth‑quarter and fiscal‑year 2026 results on Aug 3, with a press release at 1:15 p.m. PT and a live Q&A at 2 p.m. PT featuring CEO Linda Rendle and CFO Luc Bellet. Investors will be looking for evidence that the flat net sales and margin squeeze reported in the last quarter have been mitigated, as management had already trimmed fiscal 2026 guidance for net sales and gross margin. The earnings announcement will also test whether the new COO, Hyder, has begun to streamline operations and curb rising manufacturing and logistics costs that have been eroding profitability. A rebound in margins would lift the company’s valuation, which analysts view as still trading below intrinsic value despite a 38.6 % decline over five years. Even if margins improve, the firm’s 5 %+ dividend yield will remain a key attractor for income‑focused investors, potentially cushioning short‑term price swings. Analysts expect a double‑digit drop in net income and a decline in revenue due to weaker consumer demand, so the Q4 results could confirm broader pressure on household staples. The recent Goldman Sachs price target cut to $77 from $83 reflects a more cautious view of the near‑term outlook, so the market will be sensitive to any upside surprise in the earnings release. In addition, the company’s expansion into natural personal‑care and water‑filtration lines may provide a growth offset if core home‑care sales remain flat, so analysts will monitor the performance of those new categories. Traders should watch the earnings webcast for guidance revisions, margin details, and any commentary on cost‑control progress, as these factors will shape the next 1–10 trading days’ price trajectory.
Earnings Summary
Clorox, a long‑standing consumer staples manufacturer, focuses on household and healthcare essentials through brands such as Clorox, Glad, and Brita, operating in the household & personal products sector. In the most recent two quarters, Q2 2026 and Q3 2026, the company posted EPS of $1.39 and $1.64 against revenue of $1.673B and $1.670B, respectively, compared with EPS of $1.45 and $2.87 and revenue of $1.668B and $1.988B in Q1 2025 and Q2 2025; revenue growth slowed from a 19% rise in Q2 2025 to a 0.3% decline in Q3 2026, while EPS fell from a 98% jump in Q2 2025 to a modest 18% increase in Q3 2026. The firm has beaten analyst estimates in four of the six quarters with data, missing in Q1 2025 and Q2 2026, indicating a mixed but generally positive earnings track record. Historically, Clorox’s revenue has swung between modest growth and contraction, with EPS peaking in Q2 2025 and dipping in Q3 2025, yet the company has consistently delivered earnings above expectations despite revenue volatility. Recent news highlights management’s focus on cost containment amid flat net sales and margin squeeze, the appointment of a new COO, and expansion into natural personal‑care and water‑filtration lines; investors will scrutinize the upcoming Q4 2026 results for evidence of margin improvement and new‑category performance. Watch for guidance revisions, margin details, and commentary on supply‑chain and logistics cost control, as these factors will shape the next 10‑day price trajectory and inform whether the company can sustain its dividend yield while navigating cost pressures.

EPS

EstBeatMiss
$0.46$1.14$1.82$2.50$3.18Q1'25Q2'25Q3'25Q2'26Q3'26Q4'26
QtrEstActual+/−
Q4'26$1.66 - -
Q3'26$1.55$1.64+6.1%
Q2'26$1.57$1.39-11.5%
Q3'25$0.78$0.85+9.2%
Q2'25$2.21$2.87+29.7%
Q1'25$1.56$1.45-6.9%

Revenue

EstBeatMiss
$1.3B$1.5B$1.7B$1.9B$2.1BQ1'25Q2'25Q3'25Q2'26Q3'26Q4'26
QtrEstActual+/−
Q4'26$1.9B - -
Q3'26$1.7B$1.7B+0.1%
Q2'26$1.7B$1.7B+0.0%
Q3'25 - $1.4B -
Q2'25 - $2.0B -
Q1'25 - $1.7B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

CLX Stock Snapshot

CLX is currently trading at $98.95, giving The Clorox Company a market cap of 11.82B and a P/E ratio of 15.6. Today's range spans $98.21–$99.50, with shares opening at $99.50 and moving up $0.07 (0.1%) from the prior close. DailyIQ's technical score sits at 64/100 (HOLD) with a news sentiment reading of 46/100.

Over the past year CLX has traded between $84.70 and $132.03 - the current price is +16.8% off the 52-week low and -25.1% from the high. 28 analysts cover the stock with a Hold consensus and a mean 12-month target of $104.47 (range $77.00–$155.00), implying upside of +5.6%.

Neither bulls nor bears have the upper hand on The Clorox Company (CLX) right now. Score: 64/100 (HOLD). Sentiment: neutral (46/100). Price: $98.95 (in the lower half of its 52-week range). (P/E: 15.6) At 11.82B in Consumer Defensive market cap, the 52-week range of $84.70–$132.03 is the relevant frame - where the stock sits within that range, and whether volume confirms any directional move, matters more than the HOLD label alone.

In neutral phases, large-cap Consumer Defensive names like CLX are often where sector rotation debates play out quietly — at 11.82B in capitalization, the stock receives incremental allocation from funds reducing mega-cap exposure without the volatility of a small-cap entry. The 64/100 (HOLD) and neutral sentiment (46/100) at $98.95 (in the lower half of its 52-week range) describe a stock that is being considered rather than avoided.